Soleus Capital Management »

Belite Bio shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 210k 74.00

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Novocure Ord Shs (NVCR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Anthem (ELV)
Beta Bionics (BBNX)
United Therapeutics Corporation (UTHR)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Inspire Med Sys (INSP)
Twist Bioscience Corp (TWST)
Argenx Se Sponsored Adr (ARGX)
Organogenesis Hldgs (ORGO)
BioMarin Pharmaceutical (BMRN)
Cidara Therapeutics Com New (CDTX)

View all positions for Soleus Capital Management

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
Perceptive Advisors
Millennium Management
Geode Capital Management
State Street Corporation
Bnp Paribas Arbitrage, Snc
UBS Group
Citadel Advisors
Jpmorgan Chase & Co
Polymer Capital Management

View all funds holding Belite Bio